Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double-Blind, Randomized Controlled Trial Evaluating Silkworm Pupa Powder Versus Placebo in Improving Alzheimer's Disease Among Patients

NCT06898476 is registered in ClinicalTrials.gov with Zhejiang Provincial Tongde Hospital as lead sponsor.

NCT NCT06898476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06898476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double-Blind, Randomized Controlled Trial Evaluating Silkworm Pupa Powder Versus Placebo in Improving Alzheimer's Disease Among Patients
Lead sponsor
Zhejiang Provincial Tongde Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 10, 2025
Completion date
December 31, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease(ad), asthenia, sarcopenia